CNTF and amyotrophic lateral sclerosis: The first neurotrophin clinical trials tested the effects of either brain-derived neurotrophic factor (BDNF) or ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis (ALS), wherein the neurotrophin was administered by subcutaneous (SQ) administration.